Home States Delhi DCGI grants approval to Bharat Biotech for conducting trials of its intranasal...

DCGI grants approval to Bharat Biotech for conducting trials of its intranasal booster doses against Covid-19 (BBV154)

By
Dhrumit Thakkar
-
417
0
SHARE
(G.N.S) dt. 28 New Delhi The Drugs Controller General of India (DCGI) has granted approval to Bharat Biotech, the maker of Covaxin, for conducting trials of its intranasal booster doses against Covid-19 (BBV154). Trials will be conducted at nine different sites in India. “The Phase-3 clinical trial should be conducted

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   
New User Registration
*Required field

RELATED ARTICLESMORE FROM AUTHOR